GNH USA

Europe — EMA

Natriumvalproaat Seacross (Sodium Valproate)

GNH USA supplies Natriumvalproaat Seacross (Sodium Valproate), an anticonvulsant for seizures, bipolar and migraine prevention. Request a quote for supply.

Sodium Valproate

Request sourcing

1
Pack/s

What is Sodium Valproate?

Sodium Valproate, the active ingredient in Natriumvalproaat Seacross, is an anticonvulsant presented as an injectable solution for intravenous use. It is employed to treat generalized and focal seizures, to stabilise mood in bipolar disorder, and to prevent migraine attacks in appropriate patients.

GNH USA supplies Natriumvalproaat Seacross as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Sodium Valproate used for?

Sodium Valproate is an anticonvulsant that acts on neuronal excitability in several neurological and psychiatric conditions.

- Generalised and focal seizures: reduces seizure frequency and severity. - Bipolar disorder: provides mood stabilization and reduces manic episodes. - Migraine prophylaxis: decreases the number of migraine attacks and associated disability.

What are the side effects of Sodium Valproate?

Adverse reactions may occur with sodium valproate therapy.

Common Side Effects: - Nausea or gastrointestinal upset. - Dizziness or light‑headedness. - Tremor or fine motor incoordination. - Weight gain or increased appetite. - Hair thinning or loss. - Sedation or fatigue.

Serious or Rare Side Effects: - Hepatic failure or severe liver injury. - Acute pancreatitis. - Life‑threatening skin reactions such as Stevens‑Johnson syndrome. - Thrombocytopenia or significant drop in platelet count. - Hyperammonemia leading to encephalopathy. - Severe coagulation abnormalities.

What precautions apply to Sodium Valproate?

Sodium Valproate requires careful monitoring and specific safety measures. - Pregnancy contraindication: teratogenic risk (Category X); avoid use in pregnant patients. - Liver function: monitor hepatic enzymes before and during therapy. - Hematology: regular blood counts to detect thrombocytopenia or anemia. - Urea cycle disorders: contraindicated in patients with known metabolic disorders. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Sodium Valproate interact with?

Sodium Valproate can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: reduces valproate plasma levels, decreasing effectiveness. - Phenytoin: increases clearance of valproate, risking sub‑therapeutic exposure.

Moderate Interactions (Monitor Closely): - Aspirin: may increase free valproate concentrations, raising toxicity risk. - Warfarin: potentiates anticoagulant effect, requiring INR monitoring. - Lamotrigine: combined use can increase risk of serious skin reactions.

Frequently asked questions

What conditions is Natriumvalproaat Seacross used to treat?+
Natriumvalproaat Seacross contains sodium valproate, which is prescribed for the management of generalized and focal seizures, as a mood stabiliser in bipolar disorder, and for the prevention of migraine attacks. These indications are based on its anticonvulsant and neuro‑modulatory properties.
How does sodium valproate work in the body?+
Sodium valproate increases the level of the inhibitory neurotransmitter GABA by blocking its breakdown, and it also inhibits voltage‑gated sodium channels. This dual action stabilises neuronal membranes, reduces excessive neuronal firing, and helps control seizure activity and mood fluctuations.
What is the usual dose of Natriumvalproaat Seacross?+
The appropriate dose of Natriumvalproaat Seacross is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and response to therapy. Dosage adjustments are made according to therapeutic drug monitoring and individual tolerability.
Is sodium valproate safe to use during pregnancy or breastfeeding?+
Sodium valproate is classified as pregnancy Category X because it is known to cause serious birth defects and developmental disorders. It is contraindicated in pregnancy and should not be used by breastfeeding mothers unless the benefits clearly outweigh the risks and under specialist supervision.
How do I order Natriumvalproaat Seacross from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.
How does Natriumvalproaat Seacross compare with other anticonvulsants?+
Compared with other anticonvulsants, sodium valproate offers broad‑spectrum seizure control and mood‑stabilising effects, but it carries a higher risk of hepatic and hematologic toxicity. Clinicians often weigh these risks against benefits when choosing between valproate, carbamazepine, lamotrigine, or newer agents.
What are the storage and handling requirements for Natriumvalproaat Seacross?+
The injectable solution should be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the product in its original packaging to maintain stability and ensure proper temperature control during transport and storage.
How is Natriumvalproaat Seacross administered?+
Natriumvalproaat Seacross is administered intravenously by a healthcare professional. The infusion rate and volume are determined by the prescriber, and the medication should be given under appropriate clinical monitoring to observe for efficacy and potential adverse reactions.
What are the most serious risks associated with sodium valproate therapy?+
The most serious risks include severe liver injury, acute pancreatitis, life‑threatening skin reactions such as Stevens‑Johnson syndrome, and significant hematologic abnormalities like thrombocytopenia. Patients should be monitored regularly for signs of these conditions, especially during the initial months of therapy.
Who should not use Natriumvalproaat Seacross?+
Natriumvalproaat Seacross is contraindicated in pregnant women, patients with known hypersensitivity to valproate, individuals with existing liver disease, and those with urea cycle disorders. It should also be used with caution in patients with a history of pancreatitis or severe hematologic disorders.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Sodium Valproate
Route
Intravenous Use
Manufacturer
Seacross Pharma (Europe) Ltd
Origin
EU

Related products

Absenor

Absenor

Sodium Valproate

Orion Corporation
EU
Absenor

Absenor

Sodium Valproate

Orion Corporation
EU
Absenor

Absenor

Sodium Valproate

Orion Corporation
EU
Absenor Depot

Absenor Depot

Sodium Valproate

Orion Corporation
EU